Clinical Trial Update: Effect of Tolvaptan on Cognitive Function in Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tolvaptan for cognitive function in patients with cirrhosis and hepatic encephalopathy, including cases associated with hyponatremia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy
• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: Cirrhosis, Hepatic Encephalopathy | Phase 3 | Status: COMPLETED